NASDAQ · Biotechnology

Coherus BioSciences Inc (CHRS)

$0.83 -7.60%

34 In band Daily RSI (14) · 30 Oct 2026

Moving averages

SMA 200$1.56-46.79%

Company profile

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. The company is headquartered in Redwood City, California.

SectorHealthcare

IndustryBiotechnology

Market cap$159.14M

P/E ratioNone

EPS$-1.25

Beta0.988

Dividend yield0.00%

52-week high$2.62

52-week low$0.97

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 41 VRTX Vertex Pharmaceuticals Inc RSI 68 CRSP CRISPR Therapeutics AG RSI 48 IOVA Iovance Biotherapeutics Inc RSI 30 DTIL Precision Biosciences Inc RSI 56 NERV Minerva Neurosciences Inc RSI 32 IVVD Invivyd Inc RSI 37 TRDA Entrada Therapeutics Inc RSI 41 SAVA Cassava Sciences Inc IMUX Immunic Inc RSI 40

30 days of PRO Unlimited free, no card

RSI alerts for CHRS

An email when CHRS closes below RSI 30 or above 70. Nothing else.

Add alert

Data last updated 13 October 2026 at 9:39 PM EDT